CLINICAL IDENTIFICATION AND MGMT OF BW CASUALTIES

File: 092496_sep96_decls2_0003.txt
Page: 0003
Total Pages: 9

Subject: CLINICAL IDENTIFICATION AND MGMT OF BW CASUALTIES               

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003204

Folder Title: CLINICAL IDENTIFICATION AND MANAGEMENT OF BW CASUALTIES                                         

Document Number:          1

Folder SEQ  #:         23






                                                          SEERE'           UNCLASSIFIED
                        S.    Vaccination                         N


                              a.   Vaccine. Alum precipitate of the antigen in sterile filtrates of

                              cine. Strain Bacillus anthracis, available as; Human Anthrax Vaccine.


                              b.   Special Instructions. Store at 2-8 C, not frozen, protected from

                              light; shake well before withdrawing a dose.


                              C.   Imunisation Schedule. Primary course; four doses of O.Sml by intra-

                              muscular injection, at an interval of three weeks between each of the f'

                              three doses, and six months between the third and fourth doses. Some pro-

                              tection will be provided by the first vaccination and significant protec-

                              tion after the second dose.


                              d.   Adjuvant - Pertussis Vaccine. A simultaneous dose of O.Sml of

                              Pertussis vaccine, as an adjuvant, is given by intramuscular injection.


                              e.   Common Adverse Reaction. Mild erythema and swelling at the infec,

                              site may last up to 2 days. In addition there may be swelling and red

                              at the site of Pertussis vaccine.


                              f.   Contraindications.


                                   (1) None known to anthrax vaccine. The vaccine is only offered

                                   to healthy individuals.


                                   (2) Containdications to pertus5is vaccination may be more signifi-

                                   cant. It should not be given if an individual is suffering from

                                   acute illness or if there is any history of severe local or general
  reaction to any earli:er doses.




                                                               B-3 of 5
                        ROW 142 (WDSB)JA                  SEGRE'           iiuNCLASSIFIED

Document 9 f:/Week-36/BX003204/CLINICAL IDENTIFICATION AND MANAGEMENT OF BW CASUALTIES/clinical identification and mgmt of bw casualtie:0920961557092
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003204
Unit = OTSG
Parent Organization = HSC
Folder Title = CLINICAL IDENTIFICATION AND MANAGEMENT OF BW CASUALTIES
Folder Seq # = 23
Subject = CLINICAL IDENTIFICATION AND MGMT OF BW CASUALTIE
Document Seq # = 2
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 20-SEP-1996